Recurrence after treatment for high-grade dysplasia: should we modify our post-treatment surveillance protocols?
A cohort of women, having undergone an excisional procedure for high-grade cervical dysplasia, was studied to identify those patients who developed recurrent high-grade cervical dysplasia post-treatment. We have confirmed that recurrent histologically confirmed high-grade cervical dysplasia is uncommon after complete excision and appears not to occur within the first 6 months post-treatment. Post-treatment surveillance protocols should incorporate these findings.
Carter
Jonathan
J
Sydney Gynaecologic Oncology Group, Sydney Cancer Centre, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. jocarter@mail.usyd.edu.au
Sim
Janie
J
Land
Russell
R
Dalrymple
Christopher
C
Abdel-Hadi
Mohammed
M
Pather
Selvan
S
D000328:Adult; D015331:Cohort Studies; D019092:Conization; D018572:Disease-Free Survival; D005260:Female; D006801:Humans; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D009517:New South Wales / Q000453:epidemiology; D011184:Postoperative Period; D017410:Practice Guidelines as Topic; D002583:Uterine Cervical Neoplasms / Q000401:mortality* / Q000473:pathology / Q000601:surgery; D014626:Vaginal Smears / Q000592:standards*; D002578:Uterine Cervical Dysplasia / Q000401:mortality* / Q000473:pathology / Q000601:surgery